A recent study showed that rates of antiretroviral therapy in enrollees living with HIV increased over the years, but women ...

Early antiretroviral (ARV) agents had dramatic toxic side effects; since the advent of ARV therapy (ART), treatment has evolved to become more tolerable. HIV-associated neurocognitive disorders ...

Arvinas focuses on protein degradation, with its lead candidate, ARV-471, in Phase 3 trials for breast cancer. Read why we ...

Merck & Co Inc (NYSE:MRK) revealed topline results from two pivotal Phase 3 trials of a two-drug regimen of ...

The first ATR centre in a private medical college will come up at KMCH Institute of Health Sciences and Research in Coimbatore.

点击上方“感染学苑” ...

Global trends since 2005 indicate a significant decline in CD4+ count evaluations around the time of ART initiation among ...

On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-U.S. (IAS-U.S.) has ...

The compliance rate was 3.7% (179/4890) in all patients. It is 4.3% (38/881) in patients with treatment failure. Treatment failure is a burden for the patient on antiretroviral therapy, as the drug ...

A landmark achievement in its history came in 2003 when it became the first organisation in Tanzania to provide antiretroviral (ARV) therapy to patients. At the time, ARVs were prohibitively expensive ...

With antiretroviral therapy, transmission risk is minimal. HIV-positive mothers should exclusively breastfeed for six months. Infants need early HIV testing and vaccinations per national schedules.